People who get the Moderna COVID-19 vaccine reported feeling more side effects than any other vaccine patients, according to a new study.

Details of new vaccine study

The new study — published in the medical journal JAMA — used data from the Centers for Disease Control and Prevention program “v-safe.” The program uses text messages to track side effects to the COVID-19 vaccine, The Verge reports.

  • People in the program text their side effects to the CDC once every day. They noted side effects such as fatigue, arm pain, fevers, headaches and more — all symptoms of the COVID-19 vaccine, according to The Verge.

The numbers of the vaccine study

  • In total, 3.6 million people participated in the study.
  • About 67% of the participants said they had pain and/or swelling at the injection location.
  • About 55% said they had fatigue (30.9%) or chills (31.3%).
Related
‘Moderna arm’ is the latest vaccine reaction worrying people

Moderna has more reactions

According to the study, Moderna patients had more reactions. About 73% of Moderna patients had pain at the injection site compared to 65% of Pfizer patients. And 51% of Moderna patients said they had chills, fatigue and body side effects, where as 48% of Pfizer patients said the same.

  • That’s a really small difference, but it is a difference.

‘Moderna arm’

Moderna has actually made headlines for its vaccine for months, specifically because of the “Moderna arm” or “COVID arm” symptom where the injection site begins to swell, as I wrote for the Deseret News.

View Comments

Dr. George Morris told CBS Minnesota that the Moderna arm side effect isn’t a worry since it’s common among other vaccines.

  • “We’ve seen reactions like this even with other vaccines,” he said. “We know, when you get a flu vaccine, many people will have a local reaction in their arm. Tetanus vaccines. Shingles vaccines.”
Join the Conversation
Looking for comments?
Find comments in their new home! Click the buttons at the top or within the article to view them — or use the button below for quick access.